Skip to main content
Top
Published in: Journal of Neuro-Oncology 1/2016

Open Access 01-01-2016 | Clinical Study

Neurosurgical management of adult diffuse low grade gliomas in Canada: a multi-center survey

Authors: Osaama H. Khan, Warren Mason, Paul N. Kongkham, Mark Bernstein, Gelareh Zadeh

Published in: Journal of Neuro-Oncology | Issue 1/2016

Login to get access

Abstract

Adult diffuse low-grade gliomas are slow growing, World Health Organization grade II lesions with insidious onset and ultimate anaplastic transformation. The timing of surgery remains controversial with polarized practices continuing to govern patient management. As a result, the management of these patients is variable. The goal of this questionnaire was to evaluate practice patterns in Canada. An online invitation for a questionnaire including diagnostic, preoperative, perioperative, and postoperative parameters and three cases with magnetic resonance imaging data with questions to various treatment options in these patients was sent to practicing neurosurgeons and trainees. Survey was sent to 356 email addresses with 87 (24.7 %) responses collected. The range of years of practice was less than 10 years 36 % (n = 23), 11–20 years 28 % (n = 18), over 21 years 37 % (n = 24). Twenty-two neurosurgery students of various years of training completed the survey. 94 % (n = 47) of surgeons and trainees (n = 20) believe that we do not know the “right treatment”. 90 % of surgeons do not obtain formal preoperative neurocognitive assessments. 21 % (n = 13) of surgeons and 23 % of trainees (n = 5) perform a biopsy upon first presentation. A gross total resection was believed to increase progression free survival (surgeons: 75 %, n = 46; trainees: 95 %, n = 21) and to increase overall survival (surgeons: 64 %, n = 39, trainees: 68 %, n = 15). Intraoperative MRI was only used by 8 % of surgeons. Awake craniotomy was the procedure of choice for eloquent tumors by 80 % (n = 48) of surgeons and 100 % of trainees. Of those surgeons who perform awake craniotomy 93 % perform cortical stimulation and 38 % performed subcortical stimulation. Using the aid of three hypothetical cases with progressive complexities in tumor eloquence there was a trend for younger surgeons to operate earlier, and use awake craniotomy to obtain greater extent of resection with the aid of cortical stimulation when compared to senior surgeons who still more often preferred a “wait-and-see” approach. Despite the limitations of an online survey study, it has offered insights into the variability in surgeon practice patterns in Canada and the need for a consensus on the workup and surgical management of this disease.
Literature
1.
go back to reference Ahmadi R, Dictus C, Hartmann C, Zurn O, Edler L, Hartmann M, Combs S, Herold-Mende C, Wirtz CR, Unterberg A (2009) Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients. Acta Neurochir (Wien) 151:1359–1365. doi:10.1007/s00701-009-0435-x CrossRef Ahmadi R, Dictus C, Hartmann C, Zurn O, Edler L, Hartmann M, Combs S, Herold-Mende C, Wirtz CR, Unterberg A (2009) Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients. Acta Neurochir (Wien) 151:1359–1365. doi:10.​1007/​s00701-009-0435-x CrossRef
2.
go back to reference Berger MS, Deliganis AV, Dobbins J, Keles GE (1994) The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 74:1784–1791PubMedCrossRef Berger MS, Deliganis AV, Dobbins J, Keles GE (1994) The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 74:1784–1791PubMedCrossRef
3.
go back to reference Berger MS, Rostomily RC (1997) Low grade gliomas: functional mapping resection strategies, extent of resection, and outcome. J Neurooncol 34:85–101PubMedCrossRef Berger MS, Rostomily RC (1997) Low grade gliomas: functional mapping resection strategies, extent of resection, and outcome. J Neurooncol 34:85–101PubMedCrossRef
4.
go back to reference Claus EB, Horlacher A, Hsu L, Schwartz RB, Dello-Iacono D, Talos F, Jolesz FA, Black PM (2005) Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer 103:1227–1233. doi:10.1002/cncr.20867 PubMedCrossRef Claus EB, Horlacher A, Hsu L, Schwartz RB, Dello-Iacono D, Talos F, Jolesz FA, Black PM (2005) Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer 103:1227–1233. doi:10.​1002/​cncr.​20867 PubMedCrossRef
6.
go back to reference Durmaz R, Vural M, Isildi E, Cosan E, Ozkara E, Bal C, Ciftci E, Arslantas A, Atasoy MA (2008) Efficacy of prognostic factors on survival in patients with low grade glioma. Turk Neurosurg 18:336–344PubMed Durmaz R, Vural M, Isildi E, Cosan E, Ozkara E, Bal C, Ciftci E, Arslantas A, Atasoy MA (2008) Efficacy of prognostic factors on survival in patients with low grade glioma. Turk Neurosurg 18:336–344PubMed
8.
go back to reference Ius T, Isola M, Budai R, Pauletto G, Tomasino B, Fadiga L, Skrap M (2012) Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article. J Neurosurg 117:1039–1052. doi:10.3171/2012.8.JNS12393 PubMedCrossRef Ius T, Isola M, Budai R, Pauletto G, Tomasino B, Fadiga L, Skrap M (2012) Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article. J Neurosurg 117:1039–1052. doi:10.​3171/​2012.​8.​JNS12393 PubMedCrossRef
9.
go back to reference Maiuri F, Del Basso De Caro ML, Iaconetta G, Peca C, Esposito M, de Divitiis E (2006) Prognostic and survival-related factors in patients with well-differentiated oligodendrogliomas. Zentralbl Neurochir 67:204–209. doi:10.1055/s-2006-942138 PubMedCrossRef Maiuri F, Del Basso De Caro ML, Iaconetta G, Peca C, Esposito M, de Divitiis E (2006) Prognostic and survival-related factors in patients with well-differentiated oligodendrogliomas. Zentralbl Neurochir 67:204–209. doi:10.​1055/​s-2006-942138 PubMedCrossRef
10.
go back to reference McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, Olivi A, Brem H, Quinones-Hinojosa A (2008) Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery 63:700–707. doi:10.1227/01.NEU.0000325729.41085.73 author reply 707–708 PubMedCrossRef McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, Olivi A, Brem H, Quinones-Hinojosa A (2008) Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery 63:700–707. doi:10.​1227/​01.​NEU.​0000325729.​41085.​73 author reply 707–708 PubMedCrossRef
11.
go back to reference Nakamura M, Konishi N, Tsunoda S, Nakase H, Tsuzuki T, Aoki H, Sakitani H, Inui T, Sakaki T (2000) Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults. Oncology 58:108–116PubMedCrossRef Nakamura M, Konishi N, Tsunoda S, Nakase H, Tsuzuki T, Aoki H, Sakitani H, Inui T, Sakaki T (2000) Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults. Oncology 58:108–116PubMedCrossRef
14.
go back to reference Sankar T, Moore NZ, Johnson J, Ashby LS, Scheck AC, Shapiro WR, Smith KA, Spetzler RF, Preul MC (2012) Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors. J Neurosurg 116:1172–1181. doi:10.3171/2012.2.JNS102032 PubMedCrossRef Sankar T, Moore NZ, Johnson J, Ashby LS, Scheck AC, Shapiro WR, Smith KA, Spetzler RF, Preul MC (2012) Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors. J Neurosurg 116:1172–1181. doi:10.​3171/​2012.​2.​JNS102032 PubMedCrossRef
16.
go back to reference Shaw EG, Tatter SB, Lesser GJ, Ellis TL, Stanton CA, Stieber VW (2004) Current controversies in the radiotherapeutic management of adult low-grade glioma. Semin Oncol 31:653–658PubMedCrossRef Shaw EG, Tatter SB, Lesser GJ, Ellis TL, Stanton CA, Stieber VW (2004) Current controversies in the radiotherapeutic management of adult low-grade glioma. Semin Oncol 31:653–658PubMedCrossRef
17.
go back to reference Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, Tihan T, Vandenberg S, McDermott MW, Berger MS (2008) Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26:1338–1345. doi:10.1200/JCO.2007.13.9337 PubMedCrossRef Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, Tihan T, Vandenberg S, McDermott MW, Berger MS (2008) Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26:1338–1345. doi:10.​1200/​JCO.​2007.​13.​9337 PubMedCrossRef
18.
go back to reference van Veelen ML, Avezaat CJ, Kros JM, van Putten W, Vecht C (1998) Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry 64:581–587PubMedCentralPubMedCrossRef van Veelen ML, Avezaat CJ, Kros JM, van Putten W, Vecht C (1998) Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry 64:581–587PubMedCentralPubMedCrossRef
19.
go back to reference Seiz M, Freyschlag CF, Schenkel S, Weiss C, Thome C, Schmieder K, Stummer W, Tuettenberg J (2011) Management of patients with low-grade gliomas—a survey among German neurosurgical departments. Cent Eur Neurosurg 72:186–191. doi:10.1055/s-0031-1275351 PubMedCrossRef Seiz M, Freyschlag CF, Schenkel S, Weiss C, Thome C, Schmieder K, Stummer W, Tuettenberg J (2011) Management of patients with low-grade gliomas—a survey among German neurosurgical departments. Cent Eur Neurosurg 72:186–191. doi:10.​1055/​s-0031-1275351 PubMedCrossRef
20.
go back to reference Mandonnet E, Delattre JY, Tanguy ML, Swanson KR, Carpentier AF, Duffau H, Cornu P, Van Effenterre R, Alvord EC Jr, Capelle L (2003) Continuous growth of mean tumor diameter in a subset of grade II gliomas. Ann Neurol 53:524–528. doi:10.1002/ana.10528 PubMedCrossRef Mandonnet E, Delattre JY, Tanguy ML, Swanson KR, Carpentier AF, Duffau H, Cornu P, Van Effenterre R, Alvord EC Jr, Capelle L (2003) Continuous growth of mean tumor diameter in a subset of grade II gliomas. Ann Neurol 53:524–528. doi:10.​1002/​ana.​10528 PubMedCrossRef
21.
go back to reference Mandonnet E, Pallud J, Clatz O, Taillandier L, Konukoglu E, Duffau H, Capelle L (2008) Computational modeling of the WHO grade II glioma dynamics: principles and applications to management paradigm. Neurosurg Rev 31:263–269. doi:10.1007/s10143-008-0128-6 PubMedCrossRef Mandonnet E, Pallud J, Clatz O, Taillandier L, Konukoglu E, Duffau H, Capelle L (2008) Computational modeling of the WHO grade II glioma dynamics: principles and applications to management paradigm. Neurosurg Rev 31:263–269. doi:10.​1007/​s10143-008-0128-6 PubMedCrossRef
22.
go back to reference Pallud J, Mandonnet E, Duffau H, Kujas M, Guillevin R, Galanaud D, Taillandier L, Capelle L (2006) Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas. Ann Neurol 60:380–383. doi:10.1002/ana.20946 PubMedCrossRef Pallud J, Mandonnet E, Duffau H, Kujas M, Guillevin R, Galanaud D, Taillandier L, Capelle L (2006) Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas. Ann Neurol 60:380–383. doi:10.​1002/​ana.​20946 PubMedCrossRef
23.
go back to reference Soffietti R, Baumert BG, Bello L, von Deimling A, Duffau H, Frenay M, Grisold W, Grant R, Graus F, Hoang-Xuan K, Klein M, Melin B, Rees J, Siegal T, Smits A, Stupp R, Wick W (2010) Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol 17:1124–1133. doi:10.1111/j.1468-1331.2010.03151.x PubMedCrossRef Soffietti R, Baumert BG, Bello L, von Deimling A, Duffau H, Frenay M, Grisold W, Grant R, Graus F, Hoang-Xuan K, Klein M, Melin B, Rees J, Siegal T, Smits A, Stupp R, Wick W (2010) Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol 17:1124–1133. doi:10.​1111/​j.​1468-1331.​2010.​03151.​x PubMedCrossRef
26.
go back to reference Pallud J, Fontaine D, Duffau H, Mandonnet E, Sanai N, Taillandier L, Peruzzi P, Guillevin R, Bauchet L, Bernier V, Baron MH, Guyotat J, Capelle L (2010) Natural history of incidental World Health Organization grade II gliomas. Ann Neurol 68:727–733. doi:10.1002/ana.22106 PubMedCrossRef Pallud J, Fontaine D, Duffau H, Mandonnet E, Sanai N, Taillandier L, Peruzzi P, Guillevin R, Bauchet L, Bernier V, Baron MH, Guyotat J, Capelle L (2010) Natural history of incidental World Health Organization grade II gliomas. Ann Neurol 68:727–733. doi:10.​1002/​ana.​22106 PubMedCrossRef
31.
go back to reference Duffau H, Lopes M, Arthuis F, Bitar A, Sichez JP, Van Effenterre R, Capelle L (2005) Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: a comparative study between two series without (1985–96) and with (1996–2003) functional mapping in the same institution. J Neurol Neurosurg Psychiatry 76:845–851. doi:10.1136/jnnp.2004.048520 PubMedCentralPubMedCrossRef Duffau H, Lopes M, Arthuis F, Bitar A, Sichez JP, Van Effenterre R, Capelle L (2005) Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: a comparative study between two series without (1985–96) and with (1996–2003) functional mapping in the same institution. J Neurol Neurosurg Psychiatry 76:845–851. doi:10.​1136/​jnnp.​2004.​048520 PubMedCentralPubMedCrossRef
32.
go back to reference Sacko O, Lauwers-Cances V, Brauge D, Sesay M, Brenner A, Roux FE (2011) Awake craniotomy vs surgery under general anesthesia for resection of supratentorial lesions. Neurosurgery 68:1192–1198. doi:10.1227/NEU.0b013e31820c02a3; discussion 1198–1199 PubMed Sacko O, Lauwers-Cances V, Brauge D, Sesay M, Brenner A, Roux FE (2011) Awake craniotomy vs surgery under general anesthesia for resection of supratentorial lesions. Neurosurgery 68:1192–1198. doi:10.​1227/​NEU.​0b013e31820c02a3​; discussion 1198–1199 PubMed
34.
go back to reference Lo SS, Cho KH, Hall WA, Hernandez WL, Kossow RJ, Lee CK, Clark HB (2001) Does the extent of surgery have an impact on the survival of patients who receive postoperative radiation therapy for supratentorial low-grade gliomas? Int J Cancer 96(Suppl):71–78. doi:10.1002/ijc.10359 PubMedCrossRef Lo SS, Cho KH, Hall WA, Hernandez WL, Kossow RJ, Lee CK, Clark HB (2001) Does the extent of surgery have an impact on the survival of patients who receive postoperative radiation therapy for supratentorial low-grade gliomas? Int J Cancer 96(Suppl):71–78. doi:10.​1002/​ijc.​10359 PubMedCrossRef
35.
go back to reference Philippon JH, Clemenceau SH, Fauchon FH, Foncin JF (1993) Supratentorial low-grade astrocytomas in adults. Neurosurgery 32:554–559PubMedCrossRef Philippon JH, Clemenceau SH, Fauchon FH, Foncin JF (1993) Supratentorial low-grade astrocytomas in adults. Neurosurgery 32:554–559PubMedCrossRef
36.
go back to reference Soffietti R, Chio A, Giordana MT, Vasario E, Schiffer D (1989) Prognostic factors in well-differentiated cerebral astrocytomas in the adult. Neurosurgery 24:686–692PubMedCrossRef Soffietti R, Chio A, Giordana MT, Vasario E, Schiffer D (1989) Prognostic factors in well-differentiated cerebral astrocytomas in the adult. Neurosurgery 24:686–692PubMedCrossRef
38.
go back to reference Kilic T, Ozduman K, Elmaci I, Sav A, Necmettin Pamir M (2002) Effect of surgery on tumor progression and malignant degeneration in hemispheric diffuse low-grade astrocytomas. J Clin Neurosci 9:549–552PubMedCrossRef Kilic T, Ozduman K, Elmaci I, Sav A, Necmettin Pamir M (2002) Effect of surgery on tumor progression and malignant degeneration in hemispheric diffuse low-grade astrocytomas. J Clin Neurosci 9:549–552PubMedCrossRef
40.
go back to reference Scerrati M, Roselli R, Iacoangeli M, Pompucci A, Rossi GF (1996) Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery. J Neurol Neurosurg Psychiatry 61:291–296PubMedCentralPubMedCrossRef Scerrati M, Roselli R, Iacoangeli M, Pompucci A, Rossi GF (1996) Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery. J Neurol Neurosurg Psychiatry 61:291–296PubMedCentralPubMedCrossRef
41.
go back to reference Jakola AS, Myrmel KS, Kloster R, Torp SH, Lindal S, Unsgard G, Solheim O (2012) Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas. JAMA 308:1881–1888. doi:10.1001/jama.2012.12807 PubMedCrossRef Jakola AS, Myrmel KS, Kloster R, Torp SH, Lindal S, Unsgard G, Solheim O (2012) Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas. JAMA 308:1881–1888. doi:10.​1001/​jama.​2012.​12807 PubMedCrossRef
44.
go back to reference Snyder LA, Wolf AB, Oppenlander ME, Bina R, Wilson JR, Ashby L, Brachman D, Coons SW, Spetzler RF, Sanai N (2013) The impact of extent of resection on malignant transformation of pure oligodendrogliomas. J Neurosurg. doi:10.3171/2013.10.JNS13368 PubMed Snyder LA, Wolf AB, Oppenlander ME, Bina R, Wilson JR, Ashby L, Brachman D, Coons SW, Spetzler RF, Sanai N (2013) The impact of extent of resection on malignant transformation of pure oligodendrogliomas. J Neurosurg. doi:10.​3171/​2013.​10.​JNS13368 PubMed
46.
go back to reference van den Bent MJ, Taphoorn MJ, Brandes AA, Menten J, Stupp R, Frenay M, Chinot O, Kros JM, van der Rijt CC, Vecht ChJ, Allgeier A, Gorlia T (2003) Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971. J Clin Oncol 21:2525–2528. doi:10.1200/JCO.2003.12.015 PubMedCrossRef van den Bent MJ, Taphoorn MJ, Brandes AA, Menten J, Stupp R, Frenay M, Chinot O, Kros JM, van der Rijt CC, Vecht ChJ, Allgeier A, Gorlia T (2003) Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971. J Clin Oncol 21:2525–2528. doi:10.​1200/​JCO.​2003.​12.​015 PubMedCrossRef
47.
go back to reference van den Bent MJ, Chinot O, Boogerd W, Bravo Marques J, Taphoorn MJ, Kros JM, van der Rijt CC, Vecht CJ, De Beule N, Baron B (2003) Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972. Ann Oncol 14:599–602PubMedCrossRef van den Bent MJ, Chinot O, Boogerd W, Bravo Marques J, Taphoorn MJ, Kros JM, van der Rijt CC, Vecht CJ, De Beule N, Baron B (2003) Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972. Ann Oncol 14:599–602PubMedCrossRef
48.
go back to reference Blonski M, Taillandier L, Herbet G, Maldonado IL, Beauchesne P, Fabbro M, Campello C, Goze C, Rigau V, Moritz-Gasser S, Kerr C, Ruda R, Soffietti R, Bauchet L, Duffau H (2012) Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: a study of cognitive status and quality of life. J Neurooncol 106:353–366. doi:10.1007/s11060-011-0670-x PubMedCrossRef Blonski M, Taillandier L, Herbet G, Maldonado IL, Beauchesne P, Fabbro M, Campello C, Goze C, Rigau V, Moritz-Gasser S, Kerr C, Ruda R, Soffietti R, Bauchet L, Duffau H (2012) Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: a study of cognitive status and quality of life. J Neurooncol 106:353–366. doi:10.​1007/​s11060-011-0670-x PubMedCrossRef
50.
go back to reference Olson JD, Riedel E, DeAngelis LM (2000) Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 54:1442–1448PubMedCrossRef Olson JD, Riedel E, DeAngelis LM (2000) Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 54:1442–1448PubMedCrossRef
51.
go back to reference Karim AB, Maat B, Hatlevoll R, Menten J, Rutten EH, Thomas DG, Mascarenhas F, Horiot JC, Parvinen LM, van Reijn M, Jager JJ, Fabrini MG, van Alphen AM, Hamers HP, Gaspar L, Noordman E, Pierart M, van Glabbeke M (1996) A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 36:549–556PubMedCrossRef Karim AB, Maat B, Hatlevoll R, Menten J, Rutten EH, Thomas DG, Mascarenhas F, Horiot JC, Parvinen LM, van Reijn M, Jager JJ, Fabrini MG, van Alphen AM, Hamers HP, Gaspar L, Noordman E, Pierart M, van Glabbeke M (1996) A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 36:549–556PubMedCrossRef
52.
go back to reference van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, Malmstrom PO, Collette L, Pierart M, Mirimanoff R, Karim AB (2005) Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 366:985–990. doi:10.1016/S0140-6736(05)67070-5 PubMedCrossRef van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, Malmstrom PO, Collette L, Pierart M, Mirimanoff R, Karim AB (2005) Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 366:985–990. doi:10.​1016/​S0140-6736(05)67070-5 PubMedCrossRef
53.
go back to reference Buckner JC, Pugh SL, Shaw EG (2014) Phase III study of radiation therapy (RT) with or without procarbazine, CCNU, and vincristine (PCV) in low-grade glioma: RTOG 9802 with Alliance, ECOG, and SWOG. In: ASCO 2014 Buckner JC, Pugh SL, Shaw EG (2014) Phase III study of radiation therapy (RT) with or without procarbazine, CCNU, and vincristine (PCV) in low-grade glioma: RTOG 9802 with Alliance, ECOG, and SWOG. In: ASCO 2014
56.
go back to reference Duffau H, Capelle L, Sichez N, Denvil D, Lopes M, Sichez JP, Bitar A, Fohanno D (2002) Intraoperative mapping of the subcortical language pathways using direct stimulations. An anatomo-functional study. Brain 125:199–214PubMedCrossRef Duffau H, Capelle L, Sichez N, Denvil D, Lopes M, Sichez JP, Bitar A, Fohanno D (2002) Intraoperative mapping of the subcortical language pathways using direct stimulations. An anatomo-functional study. Brain 125:199–214PubMedCrossRef
58.
go back to reference Duffau H, Bauchet L, Lehericy S, Capelle L (2001) Functional compensation of the left dominant insula for language. Neuroreport 12:2159–2163PubMedCrossRef Duffau H, Bauchet L, Lehericy S, Capelle L (2001) Functional compensation of the left dominant insula for language. Neuroreport 12:2159–2163PubMedCrossRef
63.
go back to reference Sarubbo S, Le Bars E, Moritz-Gasser S, Duffau H (2012) Complete recovery after surgical resection of left Wernicke’s area in awake patient: a brain stimulation and functional MRI study. Neurosurg Rev 35:287–292. doi:10.1007/s10143-011-0351-4; discussion 292 PubMedCrossRef Sarubbo S, Le Bars E, Moritz-Gasser S, Duffau H (2012) Complete recovery after surgical resection of left Wernicke’s area in awake patient: a brain stimulation and functional MRI study. Neurosurg Rev 35:287–292. doi:10.​1007/​s10143-011-0351-4; discussion 292 PubMedCrossRef
65.
go back to reference Huse JT, Wallace M, Aldape KD, Berger MS, Bettegowda C, Brat DJ, Cahill DP, Cloughesy T, Haas-Kogan DA, Marra M, Miller CR, Nelson SJ, Salama SR, Soffietti R, Wen PY, Yip S, Yen K, Costello JF, Chang S (2013) Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) Low-grade Glioma Research Workshop. Neuro Oncol. doi:10.1093/neuonc/not229 Huse JT, Wallace M, Aldape KD, Berger MS, Bettegowda C, Brat DJ, Cahill DP, Cloughesy T, Haas-Kogan DA, Marra M, Miller CR, Nelson SJ, Salama SR, Soffietti R, Wen PY, Yip S, Yen K, Costello JF, Chang S (2013) Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) Low-grade Glioma Research Workshop. Neuro Oncol. doi:10.​1093/​neuonc/​not229
Metadata
Title
Neurosurgical management of adult diffuse low grade gliomas in Canada: a multi-center survey
Authors
Osaama H. Khan
Warren Mason
Paul N. Kongkham
Mark Bernstein
Gelareh Zadeh
Publication date
01-01-2016
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 1/2016
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-015-1949-0

Other articles of this Issue 1/2016

Journal of Neuro-Oncology 1/2016 Go to the issue